DECEMBER 2023LIFE SCIENCES REVIEW5CXO INSIGHTSLAST WORD182220242628Sherene Shakib Min, MD, MPH, VP, Head of Global Clinical Development, ViiV HealthcareHaichen Yang, MD, MA, MBA, Vice President, Clinical Research, Amicus Therapeutics IncJonathan Aceves, Global Regulatory Affairs Director - Regulatory Science, PPDCarrie Lewis, Executive Director, Clinical Program Optimization,Endo PharmaceuticalsTony Johnson, Senior Director, Global Clinical Quality Assurance, Mallinckrodt PharmaceuticalsInguna Adovica, Head of Clinical Research Quality Division, and Vadims sis, Head of Medicine and Clinical Research Department,JSC OlainfarmAlaeddin Homsi, Executive Director, Clinical Operations, BeiGene.Tony Street, Vice President for Clinical Trial Supplies, OrifarmClinical Trial Diversity in HIVHistorical control in gene therapy clinical developmentRegulatory Strategy: A Key Differentiator to Accelerate the Access of Biosimilars to the MarketsFlexibility to Change is the Key to Successful Pharma ProjectsQuality Assurance Transformations and Innovations in Pharma TechRisk-based Approach in Vendor Assessment for Clinical Trials (CT) ServicesRedefining Efficiency in Clinical OperationsMaking the Complex Look SimpleIN MY OPINION0830
< Page 4 | Page 6 >